Demographics and Outcomes of Testicular Tumors in Patients Treated at King Faisal Specialist Hospital and Research Centre, Riyadh
Testicular Tumors
DOI:
https://doi.org/10.54536/ajlsi.v3i2.3081Keywords:
Demographic Analysis, Imaging, Orchiectomy, Pathology, Testicular Cancer, Testicular Tumor, Undescended TesticlesAbstract
Testicular cancer is a relatively rare but significant malignancy, primarily affecting males between the ages of 15 and 35. The incidence and epidemiological patterns of testicular cancer vary across different geographic regions. This study aims to describe the demographics and outcomes of testicular tumors in patients treated in a tertiary setting at King Faisal Specialist Hospital and Research Centre in Riyadh. This retrospective cohort study was conducted at King Faisal Specialist Hospital and Research Centre (KFSHRC), focusing on patients across various regions in the kingdom from 2000 to 2017. The research offers a comprehensive retrospective analysis. The records of 125 males diagnosed and treated with testicular cancers with an age bracket of 14-35 years were examined. It was observed that males aged 26-35 showed the highest rate of incidence of testicular cancer. The primary differences between the progression of seminomas and nonseminomas are explored, with the latter comprising diverse subtypes such as yolk sac tumors, teratomas, embryonal carcinomas, and choriocarcinomas. This research studied patient demographics, clinical presentations, histopathological patterns, treatment modalities, and associated complications. Apart from stage 3 cases, the present research found consistency in survival outcomes, recurrence rates, and risk variables across locations. This retrospective cohort study challenges long-held beliefs and offers new insight into the treatment and prognosis of patients with testicular cancer at the KFSHRC. This study is significant because it has the potential to influence future methods of treating testicular cancer and advance knowledge of the subtleties and regional variations of the illness, which is beneficial for both patients and healthcare professionals.
Downloads
References
Abdul-Muhsin, H., Rocco, N., Navaratnam, A., Woods, M., L’Esperance, J., Castle, E., & Stroup, S. (2021). Outcomes of post-chemotherapy robot-assisted retroperitoneal lymph node dissection in testicular cancer: multi-institutional study. World Journal of Urology, 39, 3833-3838.
Abomelha, M. (2017). Adult testicular cancer: Two decades of Saudi national data. Urology Annals, 9(4), 305-309.
Alghamdi, I. G. (2023). Testicular Cancer in Saudi Arabia Between 2004 and 2017. Research and Reports in Urology, 37-45.
Altunkurek, S. Z. (2020). Testicular cancer and the importance of early diagnosis. Male Reproductive Health, 115.
Bahrami, A., Ro, J. Y., & Ayala, A. G. (2007). An overview of testicular germ cell tumors. Archives of pathology & laboratory medicine, 131(8), 1267-1280.
Baird, D. C., Meyers, G. J., & Hu, J. S. (2018). Testicular cancer: diagnosis and treatment. American family physician, 97(4), 261-268.
Bleyer, A. (2007). Young adult oncology: the patients and their survival challenges. CA: a cancer journal for clinicians, 57(4), 242-255.
Bray, F., Ferlay, J., Devesa, S. S., McGlynn, K. A., & Møller, H. (2006). Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nature clinical practice Urology, 3(10), 532-543.
Bray, F., Ren, J. S., Masuyer, E., & Ferlay, J. (2013). Global estimates of cancer prevalence for 27 sites in the adult population in 2008. International journal of cancer, 132(5), 1133-1145.
Cannarella, R., Gül, M., Rambhatla, A., & Agarwal, A. (2023). Temporal decline of sperm concentration: role of endocrine disruptors. Endocrine, 79(1), 1-16.
Cassell, A., Jalloh, M., Ndoye, M., Yunusa, B., Mbodji, M., Diallo, A., Gaye, O., Labou, I., Niang, L., & Gueye, S. (2020). Review of testicular tumor: diagnostic approach and management outcome in Africa. Research and Reports in Urology, 35-42.
Chavarriaga, J., Bobrowski, A., & Hamilton, R. J. (2023). Guideline of guidelines: follow up after orchidectomy for clinical stage 1 testicular cancer. BJU international, 132(5), 485-495.
Ergül, R. B., Bayramoğlu, Z., Keçeli, A. M., & Dönmez, M. İ. (2024). Risk for testicular germ cell tumors and spermatogenesis failure in post-pubertal undescended testes. International Urology and Nephrology, 1-6.
Fero, K. E., Lec, P. M., Sharma, V., Lenis, A. T., Low, J., Litwin, M. S., Leapman, M. S., & Chamie, K. (2021). When is a Seminoma not a Seminoma? The Incidence, Risk Factors and Management of Patients With Testicular Seminoma With Discordant Elevated Serum Alpha-fetoprotein. Urology, 157, 188-196.
Franco, A. P. D. S., Lima Figueiredo, E. R., Melo, G. S., Souza, J. D. S. E., Gonçalves, N. V., Gomes, F. D. C., & Neto, J. S. D. M. (2023). Predictors of testicular cancer mortality in Brazil: A 20-year ecological study. Cancers, 15(16), 4149.
Ghazarian, A. A., Trabert, B., Devesa, S. S., & McGlynn, K. A. (2015). Recent trends in the incidence of testicular germ cell tumors in the United States. Andrology, 3(1), 13-18.
Gilligan, T., Lin, D. W., Aggarwal, R., Chism, D., Cost, N., Derweesh, I. H., Emamekhoo, H., Feldman, D. R., Geynisman, D. M., & Hancock, S. L. (2019). Testicular cancer, version 2.2020, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 17(12), 1529-1554.
Giona, S. (2022). The epidemiology of testicular cancer. Exon Publications, 107-116.
Huyghe, E., Matsuda, T., & Thonneau, P. (2003). Increasing incidence of testicular cancer worldwide: a review. The Journal of urology, 170(1), 5-11.
Nigam, M., Aschebrook-Kilfoy, B., Shikanov, S., & Eggener, S. (2015). Increasing incidence of testicular cancer in the United States and Europe between 1992 and 2009. World Journal of Urology, 33, 623-631.
Pyle, L. C., Kim, J., Bradfield, J., Damrauer, S. M., D’Andrea, K., Einhorn, L. H., Godse, R., Hakonarson, H., Kanetsky, P. A., & Kember, R. L. (2024). Germline exome sequencing for men with testicular germ cell tumor reveals coding defects in chromosomal segregation and protein-targeting genes. European urology, 85(4), 337-345.
S., E. (2007). Cancer Incidence and Survival Report Saudi Arabia.
Safiri, S., Hassanzadeh, K., Janbaz Alamdary, S., Mousavi, S. E., Nejadghaderi, S. A., Sullman, M. J., Naghdi-Sedeh, N., & Kolahi, A.-A. (2023). The burden of testicular cancer from 1990 to 2019 in the Middle East and North Africa region. Frontiers in Oncology, 13, 1276965.
Shanmugalingam, T., Soultati, A., Chowdhury, S., Rudman, S., & Van Hemelrijck, M. (2013). Global incidence and outcome of testicular cancer. Clinical epidemiology, 417-427.
Siddiqui, B. A., Zhang, M., Pisters, L. L., & Tu, S.-M. (2020). Systemic therapy for primary and extragonadal germ cell tumors: prognosis and nuances of treatment. Translational andrology and urology, 9(Suppl 1), S56.
Siegel, R. L., Miller, K. D., & Jemal, A. (2018). Cancer statistics, 2018. CA: a cancer journal for clinicians, 68(1), 7-30.
Stephenson, A., Eggener, S. E., Bass, E. B., Chelnick, D. M., Daneshmand, S., Feldman, D., Gilligan, T., Karam, J. A., Leibovich, B., & Liauw, S. L. (2019). Diagnosis and treatment of early stage testicular cancer: AUA guideline. The Journal of urology, 202(2), 272-281.
Swerdlow, A., Schoemaker, M., Higgins, C., Wright, A., Jacobs, P., & Group, U. C. C. (2006). Cancer Incidence and Mortality in Men With Klinefelter Syndrome: A Cohort Study. The Journal of urology, 175(4), 1364-1365.
Wang, S.-C., Chang, N.-W., Chen, W.-J., Yang, M.-H., Chen, S.-L., & Sung, W.-W. (2021). Trends of testicular cancer mortality-to-incidence ratios in relation to health expenditure: An ecological study of 54 countries. International journal of environmental research and public health, 18(4), 1546.
Yazici, S., Del Biondo, D., Napodano, G., Grillo, M., Calace, F. P., Prezioso, D., Crocetto, F., & Barone, B. (2023). Risk factors for testicular cancer: environment, genes and infections—is it all? Medicina, 59(4), 724.
Znaor, A., Skakkebæk, N. E., Rajpert De Meyts, E., Laversanne, M., Kuliš, T., Gurney, J., Sarfati, D., McGlynn, K. A., & Bray, F. (2020). Testicular cancer incidence predictions in Europe 2010–2035: A rising burden despite population ageing. International journal of cancer, 147(3), 820-828.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Sultan Saud Alkhateeb, Majed Alrumayyan, Mohammed Faihan Alotaibi
This work is licensed under a Creative Commons Attribution 4.0 International License.
